Platform
Solutions
Resources
Company
- About Us
- Leadership Team
- Investors
- Press Releases
- Press Kit
- Blog
- Events
- Careers
- Partner With Us
- Contact Us
REQUEST A DEMO

More results...

More results...

Platform
- THE SOPHiA DDM™ PLATFORM
- .
  - Alamut™ Visual Plus
  - OncoPortal™ Plus
Solutions
Resources
Company
- ABOUT SOPHiA GENETICS
- USEFUL LINKS
  - Blog
  - Events
  - Careers
  - Partner With Us
  - Contact Us
REQUEST A DEMO
SIGN IN
Please select a region
FR - France
CH - Switzerland
NL - Netherlands

Home
5
Documents
5
CES_v3_RUO_ILL_BL_L01

CES_v3_RUO_ILL_BL_L01

by [email protected] | Jun 13, 2023

File Type: pdf

Categories: Instructions for Use, RUO

Tags: English

Search for:

Recent Posts

Laboratorio Curie Expands Relationship with SOPHiA GENETICS
SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform
CHU Bordeaux is live on SOPHiA GENETICS
AI-Driven Precision Oncology Summit
SOPHiA GENETICS Expands Relationship with Gustave Roussy

Recent Comments

Platform

The SOPHiA DDM™ Platform
Genomics
Multimodal
Alamut™ Visual Plus
OncoPortal™ Plus
SOPHiA GENETICS Integrated Solutions

SOLUTIONS

Oncology
Rare and Inherited Diseases
BioPharma

RESOURCES

Publications
Case Studies
Webinars
Science Hub
FAQ

Company

About Us
Leadership Team
Investors
Press Releases
Press Kit
Blog

Company

Events
Careers
Partner With Us
Contact Us
Request A Demo

© 2021 SOPHiA GENETICS. All rights reserved. Privacy Policy | Cookie Policy | Terms of Use | Sitemap

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in Europe and Turkey. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).

SOPHiA GENETICS

Platform

The SOPHiA DDM™ Platform
Genomics
Multimodal
Alamut™ Visual Plus
OncoPortal™ Plus
SOPHiA GENETICS Integrated Solutions

SOLUTIONS

Oncology
Rare and Inherited Diseases
BioPharma

RESOURCES

Publications
Case Studies
Webinars
Science Hub

Company

About Us
Leadership Team
Investors
Press Releases
Press Kit
Blog
Events
Careers
Partner With Us
Contact Us
Request A Demo

© 2021 SOPHiA GENETICS. All rights reserved. Privacy Policy | Cookie Policy | Terms of Use | Sitemap

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).

';